10.45
Schlusskurs vom Vortag:
$10.75
Offen:
$10.76
24-Stunden-Volumen:
514.76K
Relative Volume:
0.83
Marktkapitalisierung:
$610.72M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
11.00
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
-10.15%
1M Leistung:
+8.40%
6M Leistung:
-43.08%
1J Leistung:
-33.65%
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Vergleichen Sie EMBC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EMBC
Embecta Corp
|
10.45 | 628.26M | 1.12B | 55.30M | -30.30M | 0.95 |
![]()
ISRG
Intuitive Surgical Inc
|
500.51 | 178.12B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
181.54 | 52.27B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
89.18 | 45.23B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
277.44 | 40.72B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
249.21 | 18.19B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-10 | Eingeleitet | Mizuho | Neutral |
2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2022-09-08 | Eingeleitet | BTIG Research | Neutral |
2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
How does Embecta Corp. compare to its industry peersFinancial News Tracker With High Returns - jammulinksnews.com
Why Embecta Corp. stock attracts strong analyst attentionProfit Target Stock Opportunity Monitor Activated - metal.it
Fibonacci Levels Suggest Recovery for Embecta Corp.Scalable Portfolio Growth Suggestions Released - metal.it
Embecta Corp.’s Beta Climbs After Market VolatilityWeekly Hot Picks With Buy Confidence Released - metal.it
How does EMBC's Q2 2025 EPS forecast compare to past surprises? - AInvest
How did Embecta's revenue and expenses trend in Q1 2025? - AInvest
Will Embecta Corp. Reverse From Oversold ConditionsEntry Plan for Oversold Reversal Stocks Released - metal.it
Published on: 2025-07-28 16:33:37 - metal.it
Is Embecta Corp. a growth stock or a value stockInvest confidently with professional guidance - jammulinksnews.com
Why is Embecta Corp. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert help - jammulinksnews.com
What are the latest earnings results for Embecta Corp.High-octane investment gains - jammulinksnews.com
Should I hold or sell Embecta Corp. stock in 2025Get timely advice on market trends - jammulinksnews.com
What analysts say about Embecta Corp. stockSuperior return velocity - PrintWeekIndia
Should I buy Embecta Corp. stock before earningsRecord-setting profit potential - jammulinksnews.com
Is Embecta Corp. a good long term investmentDynamic portfolio growth - PrintWeekIndia
What drives Embecta Corp. stock priceAccelerated financial growth - Autocar Professional
Embecta Corp to Host Conference Call Discussing Q3 2025 Financial Results and Operational Updates - Nasdaq
embecta to Report Fiscal Third Quarter 2025 Financial Results - GlobeNewswire
Embecta Earnings Call: Medical Supply Leader to Present Q3 Results and Strategic Updates - Stock Titan
Diabetes Care Market is evolving rapidly Through 2025 To 2032 | Medtronic, Abbott, Pumps It, Inc., Embecta Corp - openPR.com
Embecta Corp. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
(EMBC) Technical Data - news.stocktradersdaily.com
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):